SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject6/11/2002 9:30:53 PM
From: Czechsinthemail   of 598
 
Catching Tularik's mid-year update at the Goldman Sachs conference is a must. There is a lot of good information about their overall plan and progress in their various research and clinical programs. Particularly interesting is Goeddel's discussion of their 5 advanced leads in the areas of immune response, inflammation, lipid disorders, obesity and diabetes. Out of the 5 advanced leads, they expect to have 1 IND by mid-year and 1 or 2 more by the end of the year.

Clearly, they are into big science with a plan to come up with blockbuster drugs. They are obviously confident that they can generate numerous targets, a significant number of good leads, and strong drug candidates they can take into clinical trials. They have an extremely strong discovery franchise that seems to be in the process of realizing some home run drugs.

I'm not sure if the conference will be archived at the Tularik website, but you should be able to reach it via the Goldman Sachs link:

gs.com.

The username will be 'conference/confd' and password will be 'healthcare'. Username and password are case-sensitive and should be all small caps. An archived webcast of the presentation will be available 24 hours after the presentation for a period of two months.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News